Saravut Satitsri

Dr. Saravut Satitsri

Chakri Naruebodindra Medical Institute, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bang Phli, Samut Prakarn 10540
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 December 2020 in Molecules
Verified
Journal Article
Open access
PDF file
SSSaravut Satitsri
Saravut Satitsri
CMChatchai Muanprasat
Chatchai Muanprasat
Chitin is a long-chain polymer of N-acetyl-glucosamine, which is regularly found in the exoskeleton of arthropods including insects, shellfish and the cell wall of fungi. It has been known that chitin can be used for biological and biomedical applications, especially as a biomaterial for tissue repairing, encapsulating drug for drug delivery. However, chitin has been postulated as an inducer of proinflammatory cytokines and certain diseases including asthma. Likewise, chitosan, a long-chain polymer of N-acetyl-glucosamine and d-glucosamine derived from chitin deacetylation, and chitosan oligosaccharide, a short chain polymer, have been known for their potential therapeutic effects, including anti-inflammatory, antioxidant, antidiarrheal, and anti-Alzheimer effects. This review summarizes potential utilization and limitation of chitin, chitosan and chitosan oligosaccharide in a variety of diseases. Furthermore, future direction of research and development of chitin, chitosan, and chitosan oligosaccharide for biomedical applications is discussed.

1 August 2015 in Biochemical Pharmacology
Verified
Journal Article
Closed access
CMChatchai Muanprasat
Chatchai Muanprasat
PWPreedajit Wongkrasant
Preedajit Wongkrasant
SSSaravut Satitsri
Saravut Satitsri
AMAekkacha Moonwiriyakit
Aekkacha Moonwiriyakit
PPPawin Pongkorpsakol
Pawin Pongkorpsakol
VCVaranuj Chatsudthipong
Varanuj Chatsudthipong

1 September 2020 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
PWPreedajit Wongkrasant
Preedajit Wongkrasant
PPPawin Pongkorpsakol
Pawin Pongkorpsakol
JAJutharat Ariyadamrongkwan
Jutharat Ariyadamrongkwan
RMRoojanaat Meesomboon
Roojanaat Meesomboon
SSSaravut Satitsri
Saravut Satitsri
CMChatchai Muanprasat
Chatchai Muanprasat
Tight junctions play an important role in maintaining barrier integrity of intestinal epithelia. Activation of AMP-activated protein kinase (AMPK) promotes tight junction assembly in intestinal epithelial cells (IEC). Fructo-oligosaccharides (FOS), well-known prebiotics, have previously been shown to alleviate inflammation-associated intestinal epithelial disruption although the mechanisms were unclear. This study aimed to investigate any effect of FOS on AMPK activity and tight junction assembly under non-inflammatory and inflammatory conditions using T84 cells as an IEC model. As analyzed by western blot, FOS induced AMPK activation through a calcium sensing receptor (CaSR)-phospholipase C (PLC)- Ca2+/calmodulin-dependent protein kinase kinase-β (CaMKKβ) pathway. Calcium switch assays and immunofluorescence staining of zonula occludens-1 (ZO-1) revealed that FOS induced tight junction assembly via an CaMKKβ-AMPK-dependent mechanism in IEC. Interestingly, FOS reversed the suppressive effect of lipopolysaccharide (LPS) on AMPK activity and tight junction assembly via a CaMKKβ pathway. Taken together, these findings uncover a prebiotic-independent effect of FOS in promoting intestinal epithelial tight junction assembly through AMPK activation, which may have implications for the treatment of diseases whose pathogenesis involves impaired intestinal barrier function.

24 May 2016 in Virulence
Verified
Journal Article
Open access
SSSaravut Satitsri
Saravut Satitsri
PPPawin Pongkorpsakol
Pawin Pongkorpsakol
PSPotjanee Srimanote
Potjanee Srimanote
VCVaranuj Chatsudthipong
Varanuj Chatsudthipong
CMChatchai Muanprasat
Chatchai Muanprasat
Cholera is caused by infection with Vibrio cholerae. This study aimed to investigate the pathophysiology of diarrhea caused by the V. cholerae O1 El Tor variant (EL), a major epidemic strain causing severe diarrhea in several regions. In the ligated ileal loop model of EL-induced diarrhea in the ICR mice, a cystic fibrosis transmembrane conductance regulator (CFTR) inhibitor and a calcium-activated chloride channel (CaCC) inhibitor similarly inhibited intestinal fluid secretion. In addition, barrier disruption and NF-κB-mediated inflammatory responses, e.g., iNOS and COX-2 expression, were observed in the infected ileal loops. Interestingly, intestinal fluid secretion and barrier disruption were suppressed by NF-κB and COX-2 inhibitors, whereas an iNOS inhibitor suppressed barrier disruption without affecting fluid secretion. Furthermore, EP2 and EP4 PGE2 receptor antagonists ameliorated the fluid secretion in the infected ileal loops. The amount of cholera toxin (CT) produced in the ileal loops by the EL was ∼2.4-fold of the classical biotype. The CT transcription inhibitor virstatin, a toll-like receptor-4 (TLR-4) antibody and a CT antibody suppressed the EL-induced intestinal fluid secretion, barrier disruption and COX-2 expression. The CT at levels detected during EL infection induced mild intestinal barrier disruption without inducing inflammatory responses in mouse intestine. Collectively, this study indicates that CT-induced intestinal barrier disruption and subsequent TLR-4-NF-κB-mediated COX-2 expression are involved in the pathogenesis of EL-induced diarrhea and represent promising novel therapeutic targets of cholera.

1 April 2025 in Drug Design, Development and Therapy
Verified
Journal Article
Open access
PDF file
CYChamnan Yibcharoenporn
Chamnan Yibcharoenporn
CMChatchai Muanprasat
Chatchai Muanprasat
AMAekkacha Moonwiriyakit
Aekkacha Moonwiriyakit
SSSaravut Satitsri
Saravut Satitsri
NPNutthapoom Pathomthongtaweechai
Nutthapoom Pathomthongtaweechai
The intestines play essential roles in nutrient absorption and immune function and help maintain a protective barrier. Disruptions to its function can result in various diseases, including metabolic disorders, inflammation, and cancer. As a key regulator of cellular energy levels, 5’-adenosine monophosphate-activated protein kinase (AMPK) is essential for intestinal health. Beyond its established metabolic role, emerging evidence suggests that AMPK exerts profound effects on intestinal cell physiology, influencing cell proliferation and differentiation, inflammation, autophagy, barrier integrity, and smooth muscle contractility. Here, we explore the structure and regulation of AMPK, as well as its diverse roles in intestinal diseases and potential as a therapeutic target. Our findings reveal that AMPK is a multifaceted regulator of intestinal health, modulating various cellular processes and intestinal diseases. It plays a dual role in cancer, acting as both a tumor suppressor and promoter, and it regulates inflammatory pathways, autophagy, tight junction formation, and smooth muscle contractility. Both natural and synthetic AMPK activators offer promise as therapeutic agents. This review of AMPK’s mechanisms and activators offers valuable insights for developing novel therapies for intestinal disorders. Further research is needed to fully define AMPK’s roles and therapeutic potential.

1 March 2017 in European Journal of Pharmacology
Verified
Journal Article
Closed access
PPPawin Pongkorpsakol
Pawin Pongkorpsakol
SSSaravut Satitsri
Saravut Satitsri
PWPreedajit Wongkrasant
Preedajit Wongkrasant
PCPamorn Chittavanich
Pamorn Chittavanich
SKSuticha Kittayaruksakul
Suticha Kittayaruksakul
CMChatchai Muanprasat
Chatchai Muanprasat